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signaling, and which are mediated via 
inhibition of MITF? Because GSK3β 
inhibits β-catenin function in canoni-
cal Wnt signaling by causing β-catenin 
degradation, the putative inhibition 
of GSK3β activity (via serine 9 phos-
phorylation and lower protein level) 
in the context of DKK1 exposure and 
Wnt pathway inhibition is paradoxical. 
GSK3β can directly phosphorylate and 
activate MITF (Takeda et al., 2000), 
and inhibition of GSK3β may inhibit 
MITF independently of β-catenin. 
Third, is DKK1 the only or main signal 
that mediates the unfavorable mela-
nocytic environment in palmoplantar 
skin? Fourth, and most fundamen-
tal, how is the regional expression of 
DKK1 in fibroblasts controlled?
In summary, the data of Yamaguchi 
et al. (2007) add to the evidence that 
regional variation of skin is patterned 
by reciprocal epithelial–mesenchymal 
interactions. Fibroblasts from differ-
ent anatomic sites are systematically 
differentiated according to their posi-
tion along three developmental axes 
and retain key features of the embry-
onic positional memory in the form 
of site-specific Hox gene expression 
(Chang et al., 2002; Rinn et al., 2006). 
Palmoplantar fibroblasts are able to 
reprogram trunk keratinocytes in cocul-
ture to induce palmoplantar keratin and, 
via elaboration of DKK1, help induce 
hypopigmentation of palmoplantar skin 
(Yamaguchi et al., 1999; Yamaguchi et 
al., 2007). A better understanding of 
these molecular mechanisms should 
shed light on the etiologies of melano-
cytic diseases, such as vitiligo and acral 
lentiginous melanoma, which demon-
strate unique anatomic predilection 
and natural histories.
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The Dumb ErbB Receptor Helps 
Healing
Yves G. Poumay1
ErbB3 receptor is a member of the epidermal growth factor (EGF) receptor 
(ErbB1) family. Okwueze et al. have transfected this receptor in a pig model 
of wounds and demonstrate that it accelerates the resurfacing of the wounds 
when combined with epiregulin or heparin-binding EGF. Currently, only 
hypotheses can be proposed to explain the observations.
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The cellular environment has a crucial 
influence on the normal physiology 
of skin cells, dermal and epidermal. 
Indeed, cell behavior is under the con-
trol of interactions with the extracel-
lular matrix and with neighboring cell 
partners, but it is also under the con-
trol of bathing growth factors and cyto-
kines. After cutaneous wounding, the 
surviving cells present in the vicinity of 
the injured tissue must receive trigger-
ing information in order to initiate and 
maintain a proper physiology during 
the tissue reconstruction. The dermal 
response and the epidermal reaction 
have complementary though very dif-
ferent goals during healing. While der-
mal cells have to elaborate the granu-
lation tissue, epidermal cells are com-
mitted to resurface the wound in order 
to repair the epidermal barrier.
Growth factors are involved at several 
levels during wound healing, and their 
addition in pharmacological amounts 
benefits the initiation and maintenance 
of neoangiogenesis, extracellular matrix 
secretion, and cell migration and pro-
liferation (for a comprehensive review, 
see Werner and Grose, 2003). In order 
to re-epithelialize the wound by kera-
tinocyte migration and proliferation, 
growth factors such as the epidermal 
growth factor (EGF) and relatives have 
demonstrated some efficacy (Werner 
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and Grose, 2003). The family of growth 
factors related to EGF contains approx-
imately a dozen members that exhibit 
various affinities for the four receptors 
of the ErbB family, whose members are 
similar in molecular structure to the 
EGF receptor (or ErbB1) embedded in 
the plasma membrane and contain a 
cytoplasmic tyrosine kinase domain 
that can be activated by ligand bind-
ing (Yarden and Sliwkowski, 2001).
When activated, members of the ErbB 
family form homodimers, but also het-
erodimers with the other members of 
the family, and phosphorylate several 
tyrosine residues present in the cyto-
plasmic domains. The paired associa-
tions of the four ErbB family members 
define a combinatorial possibility of 
ten different dimers of receptors able to 
induce multiple signals in target cells 
(Yarden and Sliwkowski, 2001). Such 
a multiplicity of ligands and receptors 
creates a rather complex signaling net-
work controlling sometimes opposite 
processes: cell survival and death, cell 
proliferation and differentiation, cell 
motility and adhesion.
In epidermal keratinocytes, the pos-
sibilities for the formation of active 
homo- and heterodimers of ErbB fam-
ily members are lower. Indeed, there 
have been several demonstrations 
that the ErbB4 receptor is absent in 
this cell type (for example, De Potter 
et al., 2001). Furthermore, it has been 
observed that ErbB2 has no ligand 
(deaf ErbB receptor) and that ErbB3 
exhibits a defective tyrosine kinase 
domain (dumb ErbB receptor) (Citri 
et al., 2003). Thus, the ErbB signal-
ing network is more simple in this cell 
type, with only four combinations of 
ErbB members able to receive induc-
tion and transmit signaling (Figure 1).
So far, the epidermal involvement 
of signaling through ErbB recep-
tors, particularly in the re-epitheli-
alization process during the healing 
of skin wounds, has drawn a lot of 
attention toward the possibility of 
using formulations that contain EGF-
like factors in order to accelerate the 
process (Werner and Grose, 2003). 
Moreover, since the use of growth fac-
tors gave moderate acceleration only, 
Nanney et al. (2000) have shown that 
an increased expression of the EGF 
receptor (ErbB1) by an in vivo trans-
fection stimulates the resurfacing of 
wounds. The same group now reports 
for the first time that transfection of 
the less studied ErbB3 dumb recep-
tor can also accelerate healing in an 
in vivo model (Okwueze et al., 2007). 
This acceleration proves to be espe-
cially relevant when ErbB3 transfec-
tion is combined with epiregulin and 
heparin-binding EGF-like growth fac-
tor (HB-EGF), two EGF-like ligands 
targeting ErbB1 and ErbB4 receptors 
(Yarden and Sliwkowski, 2001). Such a 
role for ErbB3 is intriguing. This recep-
tor is normally expressed in epider-
mal cells, but its expression is weak 
in proliferative keratinocytes and then 
upregulated together with ErbB2 in 
differentiating keratinocytes only (De 
Potter et al., 2001; Stoll et al., 2001). 
Indeed, both receptors can eventually 
be phosphorylated on tyrosine resi-
dues only upon incubation with neu-
regulin-1 (De Potter et al., 2001).
Investigations of a role for ErbB3 in 
wound healing have to be pursued, but 
this new study (Okwueze et al., 2007) 
already shows significant improve-
ments due to ErbB3 when comparing 
wounds treated with growth factors 
and empty vector, with wounds treat-
ed with growth factors and transfected 
to express ErbB3. The results show a 
highly efficient resurfacing (re-epi-
thelialization) when ErbB3 transfec-
tion is combined with epiregulin or 
with HB-EGF, the efficiency being 
suggested mostly by measurements 
of parameters that reveal normaliza-
tion of the skin under the epidermis. 
When Okwueze et al. (2007) tried to 
evaluate the expression of ErbB3 after 
transfection, their approach using 
quantitative reverse transcription PCR 
revealed a ninefold increase of the 
expression of the transcript encoded 
by the ErbB3 gene. However, sur-
prisingly, they could not find any 
enhanced detection of the receptor 
protein. Maybe a very quick degrada-
tion of the ErbB3 receptor can be sug-
gested by these observations, but the 
beneficial effect of ErbB3 transfection 
is real according to the other data.
Presently, no valid explanation can 
be given before more studies of ErbB3 
protein expression prove its localiza-
tion and real involvement in the pig 
wound healing model. Nevertheless, 
in view of the currently available lit-
erature, it is tempting to speculate on 
one possible explanation that puts 
transfected ErbB3 in a context where 
the receptor can help healing: as the 
transfection is very probably maximal 
in migrating and proliferating kera-
tinocytes, as has been demonstrated 
previously (Nanney et al., 2000) with 
the procedure used by Okwueze et 
al. (2007), then the ErbB3 expression 
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Transfection of the less 
studied ErbB3 dumb 
receptor can also 
accelerate healing in an 
in vivo model.




Figure 1. ErbB receptors in the epidermis. Only ErbB1, ErbB2, and ErbB3 are expressed in the 
epidermis. The three receptors can form six different homo- and heterodimers. Among them, the ErbB2–




would appear in cells that normally 
express this receptor poorly (De Potter 
et al., 2001). In this case, the possibil-
ity of a heterodimerization between 
EGFR and ErbB3 creates a situation 
well known to induce activation of 
phosphatidylinositol-3-kinase (Soltoff 
et al., 1994). This activation could 
then be of the highest interest for the 
repair of the epidermis, as is strongly 
suggested by another study published 
very recently (Pankow et al., 2006).
Thus, despite its defective tyrosine 
kinase domain, the receptor encoded 
by the ErbB3 gene, still poorly studied 
in skin cells, could be the ErbB family 
member that helps healing. Whether 
involvement of ErbB3 is due to its 
direct activation by an EGF-like ligand 
such as epiregulin or HB-EGF, as is 
suggested by Okwueze et al. (2007) 
but not shown previously in the litera-
ture (Elenius et al., 1997), or whether 
its activation results from heterodi-
merization with ErbB1 (EGF receptor) 
remains to be determined. There is no 
doubt, however, that more attention 
on the dumb tyrosine kinase receptor 
will help the further identification of 
its potential for wound healing.
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